Ambitna

Ambitna is a private U.S.-headquartered healthcare technology company focused on accelerating clinical research through an AI-enabled clinical trials infrastructure. The company appears to connect health systems, life sciences organizations, and technology partners to improve patient identification and matching for clinical studies, with an emphasis on improving access and health equity. Publicly available descriptions position Ambitna as a clinical trial accelerator rather than a therapeutic developer, with activity centered on software, data infrastructure, and trial enablement. Its disclosed focus areas include oncology and cardiovascular research, and it has announced at least one partnership related to AI-driven patient engagement for clinical trials.